—We sought to evaluate continuous ultrasound contrast infusion Optison® as an adjunct to color duplex ultrasound (CDU) in endoleak detection.
Methods
—Endoleak surveillance, including CDU, Optison®, and computed tomography (CTA), was performed during 18 examinations. One (3 ml) vial of Optison® was diluted in a 57-ml syringe of normal saline (total 60 ml) and administered by infusion pump at 4 ml/hr. Transverse and sagittal views were performed of the aortic aneurysm sac, endograft, and arteries outside the aneurysm sac. Primary endpoints were endograft patency, the presence or absence of endoleak, and limb dysfunction.
Results
—There were no adverse events related to the contrast agent. Contrast appearance through the endograft occurred after an average of 1 min using a mean of 46.8 ml of contrast infusion per patient. There were 10 enodleaks clearly identified by CDU and Optison®, i.e., 2 type I, 4 type II, and 2 type III endoleaks with an additional study suspicious for endoleak. Using CDU and CTA, we found 9 studies without endoleaks whereas with Optison®, we found 8 studies normal. Comparatively, when using CTA, we identified only 2 definitive endoleaks. Of the 9 endoleaks identified by using CDU and Optison®, 2 of the endoleaks were type I and not observed on conventional CTA and were later confirmed by arteriogram. One study was deemed negative by CDU and Optison® whereas CTA results were suspicious. Body habitus was prohibitive for definitive CDU findings in one patient.
Conclusions
—Using continuous ultrasound contrast infusion as an adjunct to CDU allowed for longer imaging time and more extensive evaluation of the endograft, the aneurysm sac, and the perianeurysmal arteries in these patients. Our early results demonstrate that the use of ultrasound contrast for endoleak detection is reliable and may be considered a primary surveillance modality after endovascular aortic aneurysm repair.
Get full access to this article
View all access options for this article.
References
1.
WolfY.G., JohnsonB.L., HillB.B.Duplex ultrasonography scanning versus computed tomography angiography for postoperative evaluation of endovascular abdominal aortic aneurysm repair. J Vasc Surg.2000; 32: 1142–1148.
2.
ArkoF.R., FilisK.A., HeikkinenM.A.Duplex scanning after endovascular aneurysm repair: an alternative to computed tomography. Semin Vasc Surg.2004; 17: 161–165.
3.
ChutterT.A.M., FaruqiR.M., SawhneyR.Endoleak after Endovascular Repair of Abdominal Aortic Aneurysm. J Vasc Surg.2001; 34: 98–105.
4.
SatoD.T., GoffC.D., GregoryR.T.Endoleak after aortic stent graft repair: diagnosis by color duplex ultrasound scan versus computed tomography scan. J Vasc Surg.1998; 28: 657–663.
5.
ShiW.T., FlemmingF., MerrittC.R.B., GoldbergB.B.New contrast media boost image quality. Advanced Ultrasound. Supplement Nov 2005 Issue Diagnostic Imaging.com. Available at: http://www.diagnosticimaging.com/AdvancedUS/contrast.jhtml. Accessed December 18, 2006.
6.
General Electric Healthcare. Optison (Perflutren Protein-Type A Microspheres for Injection, USP). Available at: http://www.amershamhealth-us.com/optison/. Accessed December 18, 2006.
NelmsC., CarterK., MeierG.A technique to improve the confidence of color duplex ultrasound assessment of aortic endografts: the use of contrast agents (presented at the SVT 25th Annual Conference. 2002. July 31- August 4. New Orleans, La). J Vasc Ultrasound.2003; 27: 88–92.
9.
BendickP.J.Contrast enhanced duplex ultrasound [Abstract]. Presented at the SVU 27th Annual Conference. June 3–5, 2004. Anaheim, CA.
10.
WainR.A., MarinM.L., OhkiT.Endoleaks after endovascular graft treatment of aortic aneurysms: classification, risk factors, and outcome. J Vasc Surg1998; 27: 69–80.
